3.82
price down icon0.26%   -0.01
after-market After Hours: 3.82
loading
Intensity Therapeutics Inc stock is traded at $3.82, with a volume of 20,760. It is down -0.26% in the last 24 hours and down -12.18% over the past month. Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.
See More
Previous Close:
$3.83
Open:
$3.86
24h Volume:
20,760
Relative Volume:
1.78
Market Cap:
$53.49M
Revenue:
-
Net Income/Loss:
$-10.54M
P/E Ratio:
-1.6895
EPS:
-2.261
Net Cash Flow:
$-7.21M
1W Performance:
-4.50%
1M Performance:
-12.18%
6M Performance:
-26.54%
1Y Performance:
-3.78%
1-Day Range:
Value
$3.75
$3.97
1-Week Range:
Value
$3.50
$4.0735
52-Week Range:
Value
$2.0101
$11.44

Intensity Therapeutics Inc Stock (INTS) Company Profile

Name
Name
Intensity Therapeutics Inc
Name
Phone
203-221-7381
Name
Address
61 WILTON ROAD, 3RD FLOOR, WESTPORT
Name
Employee
17
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
INTS's Discussions on Twitter

Intensity Therapeutics Inc Stock (INTS) Latest News

pulisher
Sep 26, 2024

Head and Neck Cancer Therapeutics Market Overview: Breakthrough Treatments, Technological Innovations, and ... - WhaTech

Sep 26, 2024
pulisher
Sep 24, 2024

An Analysis of Ideaya Biosciences Inc (IDYA)’s Potential Price Growth - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Weekly Investment Analysts’ Ratings Changes for Incyte (INCY) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Inogen: Upside Seems Limited After Big Move Up (NASDAQ:INGN) - Seeking Alpha

Sep 24, 2024
pulisher
Sep 24, 2024

InvenTrust Properties (NYSE:IVT) Sees Strong Trading Volume - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Skandinaviska Enskilda Banken AB publ Increases Position in Itron, Inc. (NASDAQ:ITRI) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Ideaya Biosciences price target lowered to $52 from $54 at Wedbush - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

Hoosier Hysterics Podcast: Sisley commits, plus IUWBBs Shay Ciezki and Karoline Striplin - 247Sports

Sep 24, 2024
pulisher
Sep 24, 2024

Ideaya Biosciences should be bought on weakness, says Citi - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

Intapp, Inc. (NASDAQ:INTA) Shares Sold by Hood River Capital Management LLC - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

(TIL) Long Term Investment Analysis - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Itim Group PLC Announces Strong Mid-Year Financials - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

ITT Educational Services (OTCMKTS:ESINQ) Stock Price Passes Above Two Hundred Day Moving Average of $0.00 - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

InvenTrust Properties Corp. Announces Upsizing and Pricing of Common Stock Offering - StockTitan

Sep 23, 2024
pulisher
Sep 23, 2024

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Intense Technologies Limited's (NSE:INTENTECH) CEO For Now - Simply Wall St

Sep 23, 2024
pulisher
Sep 23, 2024

US FDA Closes Out Problem Applications One Federal Register Notice At A Time - Pink Sheet

Sep 23, 2024
pulisher
Sep 23, 2024

Ideaya Biosciences price target lowered to $66 from $68 at Stifel - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

BTIG maintains $62 target on Ideaya Biosciences stock - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

From Statins to PSCK9 Inhibitors: Choosing the Right Therapy for Cholesterol - Pharmacy Times

Sep 23, 2024
pulisher
Sep 23, 2024

Intercontinental Exchange, Inc. (NYSE:ICE) Shares Sold by Interval Partners LP - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

ILLIT Comeback 'I'll Like You' Mini-Album: Release Date, Tracklist - J-14

Sep 23, 2024
pulisher
Sep 23, 2024

Integra Lifesciences Holdings Corp (IART) Becoming More Attractive for Investors - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Itau Unibanco Holding S.A. Acquires New Position in Incyte Co. (NASDAQ:INCY) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

ILLIT Announce First Comeback With Upcoming Mini-Album ‘I’LL LIKE YOU’ - Billboard Philippines

Sep 23, 2024
pulisher
Sep 23, 2024

ILLIT announces 2nd mini-album I'LL LIKE YOU, set for October 21 release, marking comeback 7 months after debut - PINKVILLA

Sep 23, 2024
pulisher
Sep 23, 2024

ILLIT flaunts 'candid charm' in upcoming EP 'I'll Like You' - ABS-CBN News

Sep 23, 2024
pulisher
Sep 22, 2024

ILLIT to Make a Comeback After 7 Months with New Album in October - KBIZoom

Sep 22, 2024
pulisher
Sep 22, 2024

Itau Unibanco Holding S.A. Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

ILLIT announces the date for their first comeback - Music Mundial News

Sep 22, 2024
pulisher
Sep 22, 2024

Update: ILLIT Shares New Brand Film For Upcoming “I’LL LIKE YOU” Comeback - soompi

Sep 22, 2024
pulisher
Sep 22, 2024

Pacer Advisors Inc. Acquires 1,175,857 Shares of Titan International, Inc. (NYSE:TWI) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

ITM Power (OTCMKTS:ITMPF) Stock Price Down 4.1% - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Titan Machinery Inc. (NASDAQ:TITN) Given Average Rating of "Hold" by Brokerages - MarketBeat

Sep 22, 2024
pulisher
Sep 22, 2024

ITM Power (OTCMKTS:ITMPF) Trading Down 4.1% - MarketBeat

Sep 22, 2024
pulisher
Sep 21, 2024

Thrivent Financial for Lutherans Sells 30,265 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Thrivent Financial for Lutherans Buys 109,795 Shares of Intercontinental Exchange, Inc. (NYSE:ICE) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Pacer Advisors Inc. Buys 2,676,851 Shares of Incyte Co. (NASDAQ:INCY) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

First Eagle Investment Management LLC Raises Stake in Iteris, Inc. (NASDAQ:ITI) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Intensity Therapeutics shares rise on Buy rating from Brookline Capital - Investing.com

Sep 21, 2024
pulisher
Sep 20, 2024

Inspire Investing LLC Sells 7,991 Shares of Incyte Co. (NASDAQ:INCY) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

31,047 Shares in Incyte Co. (NASDAQ:INCY) Purchased by XTX Topco Ltd - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Inspire Investing LLC Raises Stock Holdings in Itron, Inc. (NASDAQ:ITRI) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Intensity Therapeutics shares rise on Buy rating from Brookline Capital - Investing.com India

Sep 20, 2024
pulisher
Sep 20, 2024

Independent Bank Group (NASDAQ:IBTX) PT Raised to $66.00 - MarketBeat

Sep 20, 2024
pulisher
Sep 19, 2024

Meiji Yasuda Life Insurance Co Trims Position in Incyte Co. (NASDAQ:INCY) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Victory Capital Management Inc. Lowers Stake in Ichor Holdings, Ltd. (NASDAQ:ICHR) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Intapp (NASDAQ:INTA) Sets New 12-Month High at $47.67 - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Ick Cast & Director Explain Why The Film Is Meant To Be Watched In Its Classic Form [TIFF] - Screen Rant

Sep 18, 2024
pulisher
Sep 16, 2024

Chevron pushes through barriers to provide lower carbon intensity fuel solutions - Yahoo Finance

Sep 16, 2024
pulisher
Sep 11, 2024

Intensity Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald

Sep 11, 2024
pulisher
Sep 04, 2024

Intensity Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - BioSpace

Sep 04, 2024

Intensity Therapeutics Inc Stock (INTS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
Cap:     |  Volume (24h):